Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML

Blood. 2007 Mar 1;109(5):2264-5; author reply 2265. doi: 10.1182/blood-2006-09-047225.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Follow-Up Studies
  • Humans
  • Leukemia, Myeloid, Acute / enzymology*
  • Leukemia, Myeloid, Acute / pathology*
  • Leukemia, Myeloid, Acute / surgery
  • Recurrence
  • Stem Cell Transplantation*
  • Survival Rate
  • Treatment Outcome
  • fms-Like Tyrosine Kinase 3 / metabolism*

Substances

  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3